Skip to main content

Advertisement

Log in

Fluconazole treatment ofBlastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The first known case ofBlastoschizomyces capitatus meningitis occurring in an allogeneic bone marrow recipient on steroid and cyclosporine therapy for chronic graft-versus-host disease is reported. An 11-month course of treatment with oral fluconazole resulted in resolution of the meningeal syndrome and eradication ofBlastoschizomyces capitatus from the cerebrospinal fluid. Three months after discontinuation of fluconazole the patient died due to idiopathic interstitial pneumonia and bilateral pneumothorax, without clinical signs of meningitis. Post mortem examination showed meningeal fungus invasion consistent withBlastoschizomyces capitatus infection. Oral fluconazole treatment thus did not eradicate the fungal infection, but achieved significant control of the meningitis on an outpatient basis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Salkin IF, Gordon MA, Samsonoff WA, Riedel CL Blastoschizomyces capitatus, a new combination. Mycotaxon 1985, 22: 375–380.

    Google Scholar 

  2. Martino P, Venditti M, Micozzi A, Morace G, Polonelli L, Pettoello Mantovani M, Petti MC, Burgio VL, Santini C, Serra P, Mandelli F Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Reviews of Infectious Diseases 1990, 12: 570–582.

    PubMed  Google Scholar 

  3. Venditti M, Posteraro B, Morace G, Martino P In vitro comparative activity of fluconazole and other antifungal agents againstBlastoschizomyces capitatus. Journal of Chemotherapy 1991, 3: 13–15.

    PubMed  Google Scholar 

  4. Surmont I, Vergauwen B, Marcelis L, Verbist L, Verhoef G, Boogaerts M First report of chronic meningitis caused byTrichosporon beigelii. European Journal of Clinical Microbiology and Infectious Diseases 1990, 9: 226–229.

    Google Scholar 

  5. Arndt CAS, Walsh TJ, McCully CL, Balis FM, Pizzo PA, Poplack DG Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. Journal of Infectious Diseases 1988, 157: 178–180.

    PubMed  Google Scholar 

  6. Sugar AM, Saunders C Oral fluconazole suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. American Journal of Medicine 1988, 85: 481–489.

    PubMed  Google Scholar 

  7. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP Systemic candidiasis in cancer patients. American Journal of Medicine 1984, 77, Supplement 4D: 20–27.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girmenia, C., Micozzi, A., Venditti, M. et al. Fluconazole treatment ofBlastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur. J. Clin. Microbiol. Infect. Dis. 10, 752–756 (1991). https://doi.org/10.1007/BF01972503

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972503

Keywords

Navigation